Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021.

Authors :: Jain V
Gupta K
Bhatia K
Bansal A
Arora S
Khandelwal AK
Rosenberg JR
Levisay JP
Tommaso CL
Ricciardi MJ
Qamar A
Source :: Trends in cardiovascular medicine [Trends Cardiovasc Med] 2021 Apr; Vol. 31 (3), pp. 135-140. Date of Electronic Publication: 2020 Dec 15.
Publication Year :: 2021
Abstract: As the prevalence of asymptomatic COVID-19 continues to increase, there is an increasing possibility that patients with COVID-19 may presen with ST-segment elevation myocardial infarction (STEMI). With social distancing and restricted access to preventive healthcare and emergency services, the management of acute cardiac emergencies such as myocardial infarction has suffered collateral damage. Thus far, global trends suggest a decrease in STEMI activations with possible worse outcomes due to delayed presentation and management. In this review, we discuss the challenges to STEMI management in the COVID-19 era and provide potential solutions for adherence to evidence-based therapies as the pandemic progresses into the year 2021.<br /> (Copyright © 2020. Published by Elsevier Inc.)

Subjects :: COVID-19 epidemiology
COVID-19 prevention & control
Humans
Percutaneous Coronary Intervention
ST Elevation Myocardial Infarction diagnosis
ST Elevation Myocardial Infarction etiology
COVID-19 complications
Infection Control organization & administration
ST Elevation Myocardial Infarction therapy

Full Text Access

Tools